D-1041-2018 Class III Terminated
FDA drug recall D-1041-2018 was initiated by Valeant Pharmaceuticals North America LLC on Jul 10, 2018 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton. The recall status is terminated (terminated Feb 5, 2019). Affected quantity: 306 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 15, 2018
- Initiation Date
- Jul 10, 2018
- Termination Date
- Feb 5, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 306 cartons
Product description
Diazepam Rectal Gel, 2.5 mg, TWIN PACK that Contains two pre-filled, unit-dose, rectal delivery systems with lubricating jelly and instructions for use per carton, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807; Manufactured by: DPT Laboratories, Ltd., San Antonio, TX 78215; NDC 68682-650-20.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.
Distribution pattern
Nationwide in the USA
Code information
Lot #: NBBN, Exp 02/22
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1041-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026